COVID-19 Impact on Anesthesia Drugs Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Anesthesia Drugs Industry
1.7 COVID-19 Impact: Anesthesia Drugs Market Trends
2 Global Anesthesia Drugs Quarterly Market Size Analysis
2.1 Anesthesia Drugs Business Impact Assessment - COVID-19
2.1.1 Global Anesthesia Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Anesthesia Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Anesthesia Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Anesthesia Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Anesthesia Drugs Factory Price by Manufacturers
3.3 Location of Key Manufacturers Anesthesia Drugs Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Anesthesia Drugs Market
3.5 Key Manufacturers Anesthesia Drugs Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Anesthesia Drugs Segments, By Type
4.1 Introduction
1.4.1 Propofol
1.4.2 Etomidate
1.4.3 Midazolam
1.4.4 Sevoflurane
1.4.5 Isoflurane
4.2 By Type, Global Anesthesia Drugs Market Size, 2019-2021
4.2.1 By Type, Global Anesthesia Drugs Market Size by Type, 2020-2021
4.2.2 By Type, Global Anesthesia Drugs Price, 2020-2021
5 Impact of Covid-19 on Anesthesia Drugs Segments, By Application
5.1 Overview
5.5.1 Intravenous Anesthetics
5.5.2 Inhalational Anesthetics
5.2 By Application, Global Anesthesia Drugs Market Size, 2019-2021
5.2.1 By Application, Global Anesthesia Drugs Market Size by Application, 2019-2021
5.2.2 By Application, Global Anesthesia Drugs Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Business Overview
7.1.2 Astrazeneca Anesthesia Drugs Quarterly Production and Revenue, 2020
7.1.3 Astrazeneca Anesthesia Drugs Product Introduction
7.1.4 Astrazeneca Response to COVID-19 and Related Developments
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Business Overview
7.2.2 Fresenius-Kabi Anesthesia Drugs Quarterly Production and Revenue, 2020
7.2.3 Fresenius-Kabi Anesthesia Drugs Product Introduction
7.2.4 Fresenius-Kabi Response to COVID-19 and Related Developments
7.3 AbbVie
7.3.1 AbbVie Business Overview
7.3.2 AbbVie Anesthesia Drugs Quarterly Production and Revenue, 2020
7.3.3 AbbVie Anesthesia Drugs Product Introduction
7.3.4 AbbVie Response to COVID-19 and Related Developments
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Business Overview
7.4.2 Baxter Healthcare Anesthesia Drugs Quarterly Production and Revenue, 2020
7.4.3 Baxter Healthcare Anesthesia Drugs Product Introduction
7.4.4 Baxter Healthcare Response to COVID-19 and Related Developments
7.5 B.Braun
7.5.1 B.Braun Business Overview
7.5.2 B.Braun Anesthesia Drugs Quarterly Production and Revenue, 2020
7.5.3 B.Braun Anesthesia Drugs Product Introduction
7.5.4 B.Braun Response to COVID-19 and Related Developments
7.6 Maruishi
7.6.1 Maruishi Business Overview
7.6.2 Maruishi Anesthesia Drugs Quarterly Production and Revenue, 2020
7.6.3 Maruishi Anesthesia Drugs Product Introduction
7.6.4 Maruishi Response to COVID-19 and Related Developments
7.7 Piramal
7.7.1 Piramal Business Overview
7.7.2 Piramal Anesthesia Drugs Quarterly Production and Revenue, 2020
7.7.3 Piramal Anesthesia Drugs Product Introduction
7.7.4 Piramal Response to COVID-19 and Related Developments
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Business Overview
7.8.2 Hikma Pharmaceuticals Anesthesia Drugs Quarterly Production and Revenue, 2020
7.8.3 Hikma Pharmaceuticals Anesthesia Drugs Product Introduction
7.8.4 Hikma Pharmaceuticals Response to COVID-19 and Related Developments
7.9 Mylan
7.9.1 Mylan Business Overview
7.9.2 Mylan Anesthesia Drugs Quarterly Production and Revenue, 2020
7.9.3 Mylan Anesthesia Drugs Product Introduction
7.9.4 Mylan Response to COVID-19 and Related Developments
7.10 Nhwa
7.10.1 Nhwa Business Overview
7.10.2 Nhwa Anesthesia Drugs Quarterly Production and Revenue, 2020
7.10.3 Nhwa Anesthesia Drugs Product Introduction
7.10.4 Nhwa Response to COVID-19 and Related Developments
7.11 Hengrui
7.11.1 Hengrui Business Overview
7.11.2 Hengrui Anesthesia Drugs Quarterly Production and Revenue, 2020
7.11.3 Hengrui Anesthesia Drugs Product Introduction
7.11.4 Hengrui Response to COVID-19 and Related Developments
7.12 Lunan
7.12.1 Lunan Business Overview
7.12.2 Lunan Anesthesia Drugs Quarterly Production and Revenue, 2020
7.12.3 Lunan Anesthesia Drugs Product Introduction
7.12.4 Lunan Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Anesthesia Drugs Supply Chain Analysis
8.1.1 Anesthesia Drugs Supply Chain Analysis
8.1.2 Covid-19 Impact on Anesthesia Drugs Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Anesthesia Drugs Distribution Channels
8.2.2 Covid-19 Impact on Anesthesia Drugs Distribution Channels
8.2.3 Anesthesia Drugs Distributors
8.3 Anesthesia Drugs Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Anesthesia Drugs Assessment
Table 9. COVID-19 Impact: Anesthesia Drugs Market Trends
Table 10. COVID-19 Impact Global Anesthesia Drugs Market Size
Table 11. Global Anesthesia Drugs Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Anesthesia Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Anesthesia Drugs Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Anesthesia Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Anesthesia Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Anesthesia Drugs Market Growth Drivers
Table 17. Global Anesthesia Drugs Market Restraints
Table 18. Global Anesthesia Drugs Market Opportunities
Table 19. Global Anesthesia Drugs Market Challenges
Table 20. Key Manufacturers Anesthesia Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Anesthesia Drugs Market Size, 2019 (K Units) & (US$ Million)
Table 22. Anesthesia Drugs Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Anesthesia Drugs Manufacturing Plants
Table 24. Key Manufacturers Anesthesia Drugs Market Served
Table 25. Date of Key Manufacturers Enter into Anesthesia Drugs Market
Table 26. Key Manufacturers Anesthesia Drugs Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anesthesia Drugs Market Size by Type, 2020, (US$ Million)
Table 29. Global Anesthesia Drugs Market Size by Type, 2020 (K Units)
Table 30. Global Anesthesia Drugs Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Anesthesia Drugs Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Anesthesia Drugs Market Size by Application, 2020-2021 (K Units)
Table 33. Global Anesthesia Drugs Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Anesthesia Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Anesthesia Drugs Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Anesthesia Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Anesthesia Drugs Market Size, 2019-2021 (K Units)
Table 38. US Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Anesthesia Drugs Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Anesthesia Drugs Market Size, 2019-2021 (K Units)
Table 43. Germany Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Anesthesia Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Anesthesia Drugs Market Size, 2019-2021 (K Units)
Table 50. China Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Anesthesia Drugs Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Astrazeneca Business Overview
Table 58. Astrazeneca Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Astrazeneca Anesthesia Drugs Product
Table 60. Astrazeneca Response to COVID-19 and Related Developments
Table 61. Fresenius-Kabi Business Overview
Table 62. Fresenius-Kabi Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Fresenius-Kabi Anesthesia Drugs Product
Table 64. Fresenius-Kabi Response to COVID-19 and Related Developments
Table 65. AbbVie Business Overview
Table 66. AbbVie Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. AbbVie Anesthesia Drugs Product
Table 68. AbbVie Response to COVID-19 and Related Developments
Table 69. Baxter Healthcare Business Overview
Table 70. Baxter Healthcare Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Baxter Healthcare Anesthesia Drugs Product
Table 72. Baxter Healthcare Response to COVID-19 and Related Developments
Table 73. B.Braun Business Overview
Table 74. B.Braun Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. B.Braun Anesthesia Drugs Product
Table 76. B.Braun Response to COVID-19 and Related Developments
Table 77. Maruishi Business Overview
Table 78. Maruishi Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Maruishi Anesthesia Drugs Product
Table 80. Maruishi Response to COVID-19 and Related Developments
Table 81. Piramal Business Overview
Table 82. Piramal Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Piramal Anesthesia Drugs Product
Table 84. Piramal Response to COVID-19 and Related Developments
Table 85. Hikma Pharmaceuticals Business Overview
Table 86. Hikma Pharmaceuticals Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Hikma Pharmaceuticals Anesthesia Drugs Product
Table 88. Hikma Pharmaceuticals Response to COVID-19 and Related Developments
Table 89. Mylan Business Overview
Table 90. Mylan Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Mylan Anesthesia Drugs Product
Table 92. Mylan Response to COVID-19 and Related Developments
Table 93. Nhwa Business Overview
Table 94. Nhwa Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Nhwa Anesthesia Drugs Product
Table 96. Nhwa Response to COVID-19 and Related Developments
Table 97. Hengrui Business Overview
Table 98. Hengrui Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Hengrui Anesthesia Drugs Product
Table 100. Hengrui Response to COVID-19 and Related Developments
Table 101. Lunan Business Overview
Table 102. Lunan Anesthesia Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Lunan Anesthesia Drugs Product
Table 104. Lunan Response to COVID-19 and Related Developments
Table 105. Anesthesia Drugs Distributors List
Table 106. Anesthesia Drugs Customers List
Table 107. Covid-19 Impact on Anesthesia Drugs Customers
List of FiguresFigure 1. Anesthesia Drugs Product Picture
Figure 2. Anesthesia Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Anesthesia Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Anesthesia Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Anesthesia Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Anesthesia Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Anesthesia Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Anesthesia Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Anesthesia Drugs Market Size Market Share, 2019-2021